PRIDE PHARMACY LIMITED

Active Burton-On-Trent
30 employees website.com
P

PRIDE PHARMACY LIMITED

Founded 9 Aug 2018 Active Burton-On-Trent, England 30 employees website.com
Accounts Submitted 15 Aug 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 4 Aug 2025 Next due 16 Aug 2026 3 months remaining
Net assets £2M £390K 2024 year on year
Total assets £5M £544K 2024 year on year
Total Liabilities £3M £154K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Units 3 & 4, Stretton Business Park 2 Brunel Drive Stretton Burton-On-Trent DE13 0BY England

Website

www.example.com

Full company profile for PRIDE PHARMACY LIMITED (11508893), an active company based in Burton-On-Trent, England. Incorporated 9 Aug 2018. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2018–2024)

Cash in Bank

£3.70M

Increased by £80.08k (+2%)

Net Assets

£2.28M

Increased by £390.06k (+21%)

Total Liabilities

£2.96M

Increased by £153.81k (+5%)

Turnover

£18.45M

Increased by £612.77k (+3%)

Employees

30

Increased by 1 (+3%)

Debt Ratio

56%

Decreased by 4 (-7%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 1 Shares £1.50m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Mar 20201£1.50m£1.50m

Officers

Officers

1 active 2 resigned
Status
Matthew Thomas William TurnerDirectorBritishEngland454 Jul 2023Active

Shareholders

Shareholders (1)

D-hive Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

D-hive Limited

United Kingdom

Active
Notified 9 Aug 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

D-HIVE LIMITED united kingdom
PRIDE PHARMACY LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
15 Aug 2025AccountsAnnual accounts made up to 31 Mar 2025
4 Aug 2025Confirmation StatementConfirmation statement made on 2 Aug 2025 with no updates
23 Dec 2024OfficersTermination of Rohini Aerry as director on 20 Dec 2024
3 Sept 2024AccountsAnnual accounts made up to 31 Mar 2024
3 Sept 2024Confirmation StatementConfirmation statement made on 2 Aug 2024 with no updates
15 Aug 2025 Accounts

Annual accounts made up to 31 Mar 2025

4 Aug 2025 Confirmation Statement

Confirmation statement made on 2 Aug 2025 with no updates

23 Dec 2024 Officers

Termination of Rohini Aerry as director on 20 Dec 2024

3 Sept 2024 Accounts

Annual accounts made up to 31 Mar 2024

3 Sept 2024 Confirmation Statement

Confirmation statement made on 2 Aug 2024 with no updates

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2025

8 months ago on 15 Aug 2025

Confirmation statement made on 2 Aug 2025 with no updates

8 months ago on 4 Aug 2025

Termination of Rohini Aerry as director on 20 Dec 2024

1 years ago on 23 Dec 2024

Annual accounts made up to 31 Mar 2024

1 years ago on 3 Sept 2024

Confirmation statement made on 2 Aug 2024 with no updates

1 years ago on 3 Sept 2024